Pharma has been relatively slow on the uptake of Social Media for two major reasons namely: Pharma is a heavily regulated industry and the regulators (FDA and EMA) have yet to produce any definite guidelines as to how social media can be used responsibly by pharmaceutical companies and the end-users of the products (patients) are typically not the same set of people as the decision-makers (doctors) or the purchasers (insurance companies and governments). This has created a situation where it is not obvious who to market a product to.
Don't miss out on this fantastic opportunity to network with experts in the field including:
- Andrew Widger, Director, Media Relations, EMEA, Pfizer
- John Pugh, Director of Digital and Online Communications, Boehringer Ingelheim
- Juan Ramon Amaros, e-Business Manager, Boehringer Ingelheim Espana
- Glenn Byrd, Senior Director, Regulatory Affairs, MedImmune
- Alex Butler, EMEA Marketing Communications Manager, Johnson & Johnson
- John Vieira, Senior Director, Marketing Operations, Daiichi Sankyo
- Cressida Robson, Director of Communications, Europe, Eisai
- Sara James, Global Enrolment Consultant for Europe, Lilly
- Francisco Abad-Marin, Marketing Manager, Respiratory Centre of Excellence, GSK
- Tova Turkel, Head of Social Media, British Lung Foundation
- Lee Appleyard, Head of Digital Media & Partnerships, NHS Choices
- Senior Representative, ABPI
- Social Media: Our Past, Present and the Future of Digital Health Online
Led by: Gigi Peterkin, Vice President, Digital Health, Edelman
09:30 - 16:00 - Facilitating Patient Engagement in Healthcare Issues through Social Media
Led by Deborah Mason, Founder & Director, Talkhealth Partnership
08:30 - 12:30 - Using Social Media to Facilitate your Recruitment Strategies
Led by Catherine Gutsell, Digital Marketing Manager, CK Group
12:30 - 17:00